Significance of brain natriuretic peptide in the evaluation of symptoms and the degree of left ventricular diastolic dysfunction in patients with hypertrophic cardiomyopathy
- PMID: 17243506
Significance of brain natriuretic peptide in the evaluation of symptoms and the degree of left ventricular diastolic dysfunction in patients with hypertrophic cardiomyopathy
Abstract
Introduction: Brain natriuretic peptide (BNP) correlates well with left ventricular wall hypertrophy and the severity of left ventricular outflow tract (LVOT) obstruction in patients with hypertrophic cardiomyopathy (HCM). The purpose of this study was to investigate the correlation of BNP levels with clinical status and left ventricular function in HCM patients.
Methods: In 32 patients with HCM (age 58 +/- 14 years) we evaluated: (a) the severity of dyspnea and angina; (b) BNP plasma levels; (c) left ventricular wall thickness, sphericity index and mitral regurgitation; (d) LVOT obstruction; (e) ejection fraction; (f) left ventricular diastolic function, global and regional, by tissue Doppler imaging.
Results: BNP plasma levels correlated positively with dyspnea (r = 0.460, p < 0.001), angina (r = 0.460, p = 0.008), mitral regurgitation (r = 0.600, p < 0.001), thickness of interventricular septum (r = 0.526, p = 0.002), and LVOT obstruction (r = 0.551, p = 0.001 and r = 0.603, p < 0.001 for latent obstruction), while they were negatively correlated with left ventricular sphericity index (r = -0.368, p = 0.038). BNP plasma levels were strongly correlated with E/Vp and E/Eal (Vp: flow propagation velocity, Eal: E on the lateral side of the mitral annulus), representing the left ventricular filling pressures, and with some other parameters of regional diastolic function: Ams (A at the mid-segment of the interventricular septum) r = -0.518, p = 0.002; Aas (A on the septal side of the mitral annulus) r = -0.454, p = 0.009; Aal (A on the lateral side of the mitral annulus) r = -0.467, p = 0.007. From multiple regression analysis, angina and the ratio E/Eal were the strongest predictors of BNP plasma levels.
Conclusions: BNP plasma levels in HCM patients can be used as an adjunctive objective method of evaluating cardiac dysfunction through their correlation with angina and left ventricular filling pressures.
Similar articles
-
N-terminal pro-brain natriuretic peptide is related with coronary flow velocity reserve and diastolic dysfunction in patients with asymmetric hypertrophic cardiomyopathy.J Cardiol. 2017 Oct;70(4):323-328. doi: 10.1016/j.jjcc.2017.02.008. Epub 2017 Mar 21. J Cardiol. 2017. PMID: 28336204
-
[Correlation of B-type natriuretic peptide (NT-proBNP) levels and conventional and tissue Doppler echocardiographic parameters of left ventricular diastolic function in patients with hypertrophic cardiomyopathy].Orv Hetil. 2005 Jan 2;146(1):23-6. Orv Hetil. 2005. PMID: 15715369 Hungarian.
-
Serum cardiac troponin I is related to increased left ventricular wall thickness, left ventricular dysfunction, and male gender in hypertrophic cardiomyopathy.Clin Cardiol. 2010 Feb;33(2):E1-7. doi: 10.1002/clc.20622. Clin Cardiol. 2010. PMID: 20043329 Free PMC article.
-
Relationship between measures of left ventricular systolic and diastolic dysfunction and clinical and biomarker status in patients with hypertrophic cardiomyopathy.Arch Cardiovasc Dis. 2022 Nov;115(11):598-609. doi: 10.1016/j.acvd.2022.07.002. Epub 2022 Sep 29. Arch Cardiovasc Dis. 2022. PMID: 36272967 Review.
-
Stress transient hypertrophic cardiomyopathy and B-type natriuretic peptide role.Pediatr Cardiol. 2013 Mar;34(3):702-6. doi: 10.1007/s00246-012-0317-5. Epub 2012 Apr 20. Pediatr Cardiol. 2013. PMID: 22526216 Review.
Cited by
-
Correlation between brain natriuretic peptide levels and the prognosis of patients with left ventricular diastolic dysfunction.Exp Ther Med. 2016 Jun;11(6):2583-2589. doi: 10.3892/etm.2016.3203. Epub 2016 Mar 30. Exp Ther Med. 2016. PMID: 27313677 Free PMC article.
-
Degree and distribution of left ventricular hypertrophy as a determining factor for elevated natriuretic peptide levels in patients with hypertrophic cardiomyopathy: insights from cardiac magnetic resonance imaging.Int J Cardiovasc Imaging. 2012 Apr;28(4):763-72. doi: 10.1007/s10554-011-9876-4. Epub 2011 Apr 24. Int J Cardiovasc Imaging. 2012. PMID: 21516440
-
Association of NT-proBNP and hs-cTnT with Imaging Markers of Diastolic Dysfunction and Focal Myocardial Fibrosis in Hypertrophic Cardiomyopathy.Life (Basel). 2022 Aug 16;12(8):1241. doi: 10.3390/life12081241. Life (Basel). 2022. PMID: 36013420 Free PMC article.
-
Prognostic value of brain natriuretic peptide in patients with heart failure and reserved left ventricular systolic function.Exp Ther Med. 2014 Jun;7(6):1506-1512. doi: 10.3892/etm.2014.1635. Epub 2014 Mar 27. Exp Ther Med. 2014. PMID: 24926333 Free PMC article.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources